(19)
(11) EP 2 939 634 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.08.2018 Bulletin 2018/33

(45) Mention of the grant of the patent:
27.06.2018 Bulletin 2018/26

(21) Application number: 15168256.4

(22) Date of filing: 13.11.2008
(51) International Patent Classification (IPC): 
A61F 5/56(2006.01)

(54)

ORAL DEVICE FOR IMPROVING AIRWAY PATENCY

MUNDGERÄT ZUR VERBESSERUNG DER ATEMWEGSDURCHGÄNGIGKEIT

DISPOSITIF ORALE PERMETTANT D'AMÉLIORER LA PERMÉABILITÉ DES VOIES AÉRIENNES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(30) Priority: 13.11.2007 US 987707 P

(43) Date of publication of application:
04.11.2015 Bulletin 2015/45

(62) Application number of the earlier application in accordance with Art. 76 EPC:
08849727.6 / 2209433

(73) Proprietor: Somnics, Inc.
Zhubei, Hsinchu, 30261 (TW)

(72) Inventors:
  • Vaska, Matthias
    Palo Alto, CA California 94306 (US)
  • Podmore, Jonathan
    San Carlos, CA California 94070 (US)
  • Crowe, John Edward
    Menlo Park, CA California 94025 (US)
  • Daniel, Sean Christopher
    Palo Alto, CA California 94303 (US)

(74) Representative: Charrier Rapp & Liebau 
Patentanwälte Fuggerstrasse 20
86150 Augsburg
86150 Augsburg (DE)


(56) References cited: : 
US-A- 5 957 133
US-B1- 6 675 802
 US-A1- 2005 081 859
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).